Australia markets closed

Lumos Pharma, Inc. (LUMO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.38+0.38 (+5.43%)
At close: 04:00PM EST
7.26 -0.14 (-1.89%)
After hours: 04:04PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 59.76M
Enterprise value -40.26M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.19k
Price/book (mrq)0.63
Enterprise value/revenue -805.15
Enterprise value/EBITDA 1.06

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-59.93%
S&P500 52-week change 327.77%
52-week high 336.72
52-week low 36.80
50-day moving average 38.85
200-day moving average 310.31

Share statistics

Avg vol (3-month) 318.49k
Avg vol (10-day) 325.77k
Shares outstanding 58.36M
Implied shares outstanding 6N/A
Float 84.99M
% held by insiders 128.48%
% held by institutions 134.50%
Shares short (14 Nov 2021) 459.17k
Short ratio (14 Nov 2021) 43.81
Short % of float (14 Nov 2021) 40.93%
Short % of shares outstanding (14 Nov 2021) 40.71%
Shares short (prior month 14 Oct 2021) 482.23k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Mar 2020
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021


Profit margin 0.00%
Operating margin (ttm)-63,664.00%

Management effectiveness

Return on assets (ttm)-16.40%
Return on equity (ttm)-25.58%

Income statement

Revenue (ttm)50k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)168k
EBITDA -31.36M
Net income avi to common (ttm)-27.2M
Diluted EPS (ttm)-3.27
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)100.65M
Total cash per share (mrq)12.04
Total debt (mrq)637k
Total debt/equity (mrq)0.68
Current ratio (mrq)17.47
Book value per share (mrq)11.26

Cash flow statement

Operating cash flow (ttm)-30.8M
Levered free cash flow (ttm)6.98M